PURPOSE: Transfer of genetic material from cancer cells to normal cells occurs via microvesicles. Cell specific phenotypes can be induced in normal cells by the transfer of material in microvesicles, leading to genetic changes. We report the identification and expression of prostate specific genes in normal human marrow cells co-cultured with human prostate cancer cells. MATERIALS AND METHODS: We harvested prostate tissue from 11 patients with prostate cancer. In 4 cases prostate tissue was co-cultured across from human marrow for 2 or 7 days but separated from it by a 0.4 μM polystyrene membrane. In 5 cases conditioned medium from patient cancer tissue was collected and ultracentrifuged, and microvesicles were collected for co-culture (3) and vesicle characterization (3). Explanted human marrow was harvested from cultures and RNA extracted. Real-time reverse transcriptase-polymerase chain reaction was done for select prostate specific genes. RESULTS: Marrow exposed to human prostate tumor or isolated microvesicles in culture in 4 and 3 cases, respectively, showed at least 2-fold or greater prostate gene expression than control marrow. In 1 case in which normal prostate was co-cultured there were no prostate gene increases in normal marrow. CONCLUSIONS: Prostate cancer tumor cells co-cultured with human bone marrow cells induce prostate specific gene expression. The proposed mechanism of transfer of genetic material is via microvesicles. This represents an opportunity for novel therapeutic agents, such as antibodies, to block microvesicle release from cancer cells or for agents that may block cells from accepting microvesicles.
PURPOSE: Transfer of genetic material from cancer cells to normal cells occurs via microvesicles. Cell specific phenotypes can be induced in normal cells by the transfer of material in microvesicles, leading to genetic changes. We report the identification and expression of prostate specific genes in normal human marrow cells co-cultured with humanprostate cancer cells. MATERIALS AND METHODS: We harvested prostate tissue from 11 patients with prostate cancer. In 4 cases prostate tissue was co-cultured across from human marrow for 2 or 7 days but separated from it by a 0.4 μM polystyrene membrane. In 5 cases conditioned medium from patientcancer tissue was collected and ultracentrifuged, and microvesicles were collected for co-culture (3) and vesicle characterization (3). Explanted human marrow was harvested from cultures and RNA extracted. Real-time reverse transcriptase-polymerase chain reaction was done for select prostate specific genes. RESULTS: Marrow exposed to humanprostate tumor or isolated microvesicles in culture in 4 and 3 cases, respectively, showed at least 2-fold or greater prostate gene expression than control marrow. In 1 case in which normal prostate was co-cultured there were no prostate gene increases in normal marrow. CONCLUSIONS:Prostate cancer tumor cells co-cultured with human bone marrow cells induce prostate specific gene expression. The proposed mechanism of transfer of genetic material is via microvesicles. This represents an opportunity for novel therapeutic agents, such as antibodies, to block microvesicle release from cancer cells or for agents that may block cells from accepting microvesicles.
Authors: Kevin B Hotary; Edward D Allen; Peter C Brooks; Nabanita S Datta; Michael W Long; Stephen J Weiss Journal: Cell Date: 2003-07-11 Impact factor: 41.582
Authors: Monika Baj-Krzyworzeka; Rafał Szatanek; Kazimierz Weglarczyk; Jarosław Baran; Barbara Urbanowicz; Piotr Brański; Mariusz Z Ratajczak; Marek Zembala Journal: Cancer Immunol Immunother Date: 2005-11-09 Impact factor: 6.968
Authors: Jason M Aliotta; David Lee; Napoleon Puente; Sam Faradyan; Edmund H Sears; Ashley Amaral; Laura Goldberg; Mark S Dooner; Mandy Pereira; Peter J Quesenberry Journal: Stem Cells Dev Date: 2012-02-15 Impact factor: 3.272
Authors: Peter J Quesenberry; Laura R Goldberg; Jason M Aliotta; Mark S Dooner; Mandy G Pereira; Sicheng Wen; Giovanni Camussi Journal: Stem Cells Dev Date: 2014-04-01 Impact factor: 3.272
Authors: Jasmina S Redzic; Leonora Balaj; Kristan E van der Vos; Xandra O Breakefield Journal: Semin Cancer Biol Date: 2014-04-28 Impact factor: 15.707
Authors: Jason M Aliotta; Mandy Pereira; Ming Li; Ashley Amaral; Arina Sorokina; Mark S Dooner; Edmund H Sears; Kate Brilliant; Bharat Ramratnam; Douglas C Hixson; Peter J Quesenberry Journal: J Extracell Vesicles Date: 2012-04-16
Authors: Andrew J Tompkins; Devasis Chatterjee; Michael Maddox; Justin Wang; Emily Arciero; Giovanni Camussi; Peter J Quesenberry; Joseph F Renzulli Journal: J Extracell Vesicles Date: 2015-06-30
Authors: Hillary E Mulvey; Audrey Chang; Jason Adler; Michael Del Tatto; Kimberly Perez; Peter J Quesenberry; Devasis Chatterjee Journal: BMC Cancer Date: 2015-08-01 Impact factor: 4.430